Suchergebnisse - "van de Ven, Rieneke"

  1. 1

    The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites von Wondergem, Niels E., Nauta, Irene H., Muijlwijk, Tara, Leemans, C. René, van de Ven, Rieneke

    ISSN: 1523-3790, 1534-6269, 1534-6269
    Veröffentlicht: New York Springer US 01.08.2020
    Veröffentlicht in Current oncology reports (01.08.2020)
    “… Purpose To understand why some patients respond to immunotherapy but many do not, a clear picture of the tumor microenvironment (TME) of head and neck squamous …”
    Volltext
    Journal Article
  2. 2

    Targeting C‐type lectin receptors: a high‐carbohydrate diet for dendritic cells to improve cancer vaccines von Dinther, Dieke, Stolk, Dorian A., Ven, Rieneke, Kooyk, Yvette, Gruijl, Tanja D., Haan, Joke M. M.

    ISSN: 0741-5400, 1938-3673, 1938-3673
    Veröffentlicht: Bethesda, MD, USA Society for Leukocyte Biology 01.10.2017
    Veröffentlicht in Journal of leukocyte biology (01.10.2017)
    “… Review of in vivo targeting of tumor antigens to lectin receptors on antigen‐presenting cells using antibodies or ligands may improve the antitumor efficacy of …”
    Volltext
    Journal Article
  3. 3

    Commentary on differential impact of TIM-3 ligands on NK cell function von van de Ven, Rieneke

    ISSN: 2051-1426, 2051-1426
    Veröffentlicht: England BMJ Publishing Group Ltd 11.07.2025
    Veröffentlicht in Journal for immunotherapy of cancer (11.07.2025)
    “… T-cell immunoglobin and mucin-domain containing molecule 3 (TIM-3) is an immune checkpoint receptor and a target for immune checkpoint blockers (ICBs) …”
    Volltext
    Journal Article
  4. 4

    Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy von van Pul, Kim M., Fransen, Marieke F., van de Ven, Rieneke, de Gruijl, Tanja D.

    ISSN: 1664-3224, 1664-3224
    Veröffentlicht: Switzerland Frontiers Media S.A 01.03.2021
    Veröffentlicht in Frontiers in immunology (01.03.2021)
    “… Immune checkpoint blockade (ICB) has changed the therapeutic landscape of oncology but its impact is limited by primary or secondary resistance. ICB resistance …”
    Volltext
    Journal Article
  5. 5

    Hallmarks of a genomically distinct subclass of head and neck cancer von Muijlwijk, Tara, Nauta, Irene H., van der Lee, Anabel, Grünewald, Kari J. T., Brink, Arjen, Ganzevles, Sonja H., Baatenburg de Jong, Robert J., Atanesyan, Lilit, Savola, Suvi, van de Wiel, Mark A., Peferoen, Laura A. N., Bloemena, Elisabeth, van de Ven, Rieneke, Leemans, C. René, Poell, Jos B., Brakenhoff, Ruud H.

    ISSN: 2041-1723, 2041-1723
    Veröffentlicht: London Nature Publishing Group UK 20.10.2024
    Veröffentlicht in Nature communications (20.10.2024)
    “… Cancer is caused by an accumulation of somatic mutations and copy number alterations (CNAs). Besides mutations, these copy number changes are key …”
    Volltext
    Journal Article
  6. 6

    Tumor-educated Tregs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche von Kos, Kevin, Aslam, Muhammad A., van de Ven, Rieneke, Wellenstein, Max D., Pieters, Wietske, van Weverwijk, Antoinette, Duits, Danique E.M., van Pul, Kim, Hau, Cheei-Sing, Vrijland, Kim, Kaldenbach, Daphne, Raeven, Elisabeth A.M., Quezada, Sergio A., Beyaert, Rudi, Jacobs, Heinz, de Gruijl, Tanja D., de Visser, Karin E.

    ISSN: 2211-1247, 2211-1247
    Veröffentlicht: Elsevier Inc 01.03.2022
    Veröffentlicht in Cell reports (Cambridge) (01.03.2022)
    “… Breast cancer is accompanied by systemic immunosuppression, which facilitates metastasis formation, but how this shapes organotropism of metastasis is poorly …”
    Volltext
    Journal Article
  7. 7
  8. 8
  9. 9

    Glycan-Modified Melanoma-Derived Apoptotic Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination von Horrevorts, Sophie K, Stolk, Dorian A, Ven, Rieneke van de, Hulst, Myrthe, Hof, Bert van Het, Duinkerken, Sanne, Heineke, Marieke H, Ma, Wenbin, Dusoswa, Sophie A, Nieuwland, Rienk, Garcia-Vallejo, Juan J, Loosdrecht, Arjan A van de, de Gruijl, Tanja D, Vliet, Sandra J van, van Kooyk, Yvette

    ISSN: 2072-6694, 2072-6694
    Veröffentlicht: Switzerland 01.09.2019
    Veröffentlicht in Cancers (01.09.2019)
    “… Tumors that lack T cell infiltration are less likely to respond to immune checkpoint inhibition and could benefit from cancer vaccination for the initiation of …”
    Volltext
    Journal Article
  10. 10

    Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses von Stolk, Dorian A., de Haas, Aram, Vree, Jana, Duinkerken, Sanne, Lübbers, Joyce, van de Ven, Rieneke, Ambrosini, Martino, Kalay, Hakan, Bruijns, Sven, van der Vliet, Hans J., de Gruijl, Tanja D., van Kooyk, Yvette

    ISSN: 1664-3224, 1664-3224
    Veröffentlicht: Switzerland Frontiers Media S.A 27.05.2020
    Veröffentlicht in Frontiers in immunology (27.05.2020)
    “… In this study we developed a liposome-based vaccine containing palmitoylated synthetic long peptides (SLP) and alpha galactosylceramide (αGC) to specifically …”
    Volltext
    Journal Article
  11. 11

    Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination von Horrevorts, Sophie K., Stolk, Dorian A., van de Ven, Rieneke, Hulst, Myrthe, van Het Hof, Bert, Duinkerken, Sanne, Heineke, Marieke H., Ma, Wenbin, Dusoswa, Sophie A., Nieuwland, Rienk, Garcia-Vallejo, Juan J., van de Loosdrecht, Arjan A., de Gruijl, Tanja D., van Vliet, Sandra J., van Kooyk, Yvette

    ISSN: 2072-6694, 2072-6694
    Veröffentlicht: Basel MDPI AG 28.08.2019
    Veröffentlicht in Cancers (28.08.2019)
    “… Tumors that lack T cell infiltration are less likely to respond to immune checkpoint inhibition and could benefit from cancer vaccination for the initiation of …”
    Volltext
    Journal Article
  12. 12

    Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring von Berthe, Julie, Poudel, Pawan, Segerer, Felix J., Jennings, Emily C., Ng, Felicia, Surace, Michael, Andoni, Alma, Testori, Marco, Saraiya, Megha, Vuko, Miljenka, Hessel, Harald, Heininen-Brown, Mari, Blando, Jorge, Jones, Emma V., Willis, Sophie E., Galon, Jérôme, van de Ven, Rieneke, de Gruijl, Tanja D., Angell, Helen K.

    ISSN: 1664-3224, 1664-3224
    Veröffentlicht: Switzerland Frontiers Media SA 20.09.2024
    Veröffentlicht in Frontiers in immunology (20.09.2024)
    “… Tertiary Lymphoid Structures (TLS) are lymphoid structures commonly associated with improved survival of cancer patients and response to immunotherapies …”
    Volltext
    Journal Article
  13. 13

    Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy von van de Ven, Rieneke, Reurs, Anneke W., Wijnands, Pepijn G. J. T. B., van Wetering, Sandra, Kruisbeek, Ada M., Hooijberg, Erik, Scheffer, George L., Scheper, Rik J., de Gruijl, Tanja D.

    ISSN: 0340-7004, 1432-0851, 1432-0851
    Veröffentlicht: Berlin/Heidelberg Springer-Verlag 01.02.2012
    Veröffentlicht in Cancer Immunology, Immunotherapy (01.02.2012)
    “… Appropriate activation of dendritic cells (DC) is essential for successful active vaccination and induction of cell-mediated immunity. The scarcity of …”
    Volltext
    Journal Article
  14. 14

    Editorial: Mechanisms of Lymphocyte Exclusion in the Tumor Microenvironment von van de Ven, Rieneke, Bifulco, Carlo B., Luke, Jason J., Church, Sarah E.

    ISSN: 1664-3224, 1664-3224
    Veröffentlicht: Switzerland Frontiers Media S.A 29.04.2022
    Veröffentlicht in Frontiers in immunology (29.04.2022)
    Volltext
    Journal Article
  15. 15

    Comparative phenotypic and functional analysis of migratory dendritic cell subsets from human oral mucosa and skin von Kosten, Ilona Jennifer, van de Ven, Rieneke, Thon, Maria, Gibbs, Susan, de Gruijl, Tanja D.

    ISSN: 1932-6203, 1932-6203
    Veröffentlicht: United States Public Library of Science 13.07.2017
    Veröffentlicht in PloS one (13.07.2017)
    “… Antigen exposure to oral mucosa is generally thought to lead to immune tolerance induction. However, very little is known about the subset composition and …”
    Volltext
    Journal Article
  16. 16

    Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites von Muijlwijk, Tara, Nijenhuis, Dennis N L M, Ganzevles, Sonja H, Brink, Arjen, Ke, Changlin, Fass, Joseph N, Rajamanickam, Venkatesh, Leemans, C René, Koguchi, Yoshinobu, Fox, Bernard A, Poell, Jos B, Brakenhoff, Ruud H, van de Ven, Rieneke

    ISSN: 2051-1426, 2051-1426
    Veröffentlicht: England BMJ Publishing Group Ltd 11.01.2024
    Veröffentlicht in Journal for immunotherapy of cancer (11.01.2024)
    “… BackgroundThe response rate to immune checkpoint inhibitors targeting programmed cell death 1 (PD-1) receptor is 13%–18% for patients with recurrent or …”
    Volltext
    Journal Article
  17. 17

    Richness for Tumor-Infiltrating B-Cells in the Oral Cancer Tumor Microenvironment Is a Prognostic Factor in Early-Stage Disease and Improves Outcome in Advanced-Stage Disease von Nauta, Irene H., Nijenhuis, Dennis N. L. M., Ganzevles, Sonja H., Raaff, Pamela I., Kloosterman, Jan, Bloemena, Elisabeth, Brakenhoff, Ruud H., Leemans, C. René, van de Ven, Rieneke

    ISSN: 2072-6694, 2072-6694
    Veröffentlicht: Switzerland MDPI AG 01.01.2025
    Veröffentlicht in Cancers (01.01.2025)
    “… Background/Objectives: Most studies on the interaction between the immune system and cancer focus on T-cells, whereas studies on tumor-infiltrating …”
    Volltext
    Journal Article
  18. 18

    NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models von Gruijs, Mandy, Ganzevles, Sonja H., Stigter-van Walsum, Marijke, van der Mast, Richard, van Ostaijen-ten Dam, Monique M., Tuk, Cornelis W., Schilham, Marco W., Leemans, C. René, Brakenhoff, Ruud H., van Egmond, Marjolein, van de Ven, Rieneke, Bakema, Jantine E.

    ISSN: 1422-0067, 1661-6596, 1422-0067
    Veröffentlicht: Switzerland MDPI AG 14.10.2021
    Veröffentlicht in International journal of molecular sciences (14.10.2021)
    “… The immunosuppressive character of head and neck cancers may explain the relatively low response rates to antibody therapy targeting a tumor antigen, such as …”
    Volltext
    Journal Article
  19. 19

    Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node von van Pul, Kim M., Vuylsteke, Ronald J.C.L.M., van de Ven, Rieneke, te Velde, Elisabeth A., Rutgers, Emiel J. Th, van den Tol, Petrousjka M., Stockmann, Hein B.A.C., de Gruijl, Tanja D.

    ISSN: 2051-1426, 2051-1426
    Veröffentlicht: London BioMed Central 22.05.2019
    Veröffentlicht in Journal for immunotherapy of cancer (22.05.2019)
    “… Background Immune regulated pathways influence both breast cancer (BrC) development and response to (neo)adjuvant chemotherapy. The sentinel lymph node (SLN), …”
    Volltext
    Journal Article
  20. 20

    Immune cell topography of head and neck cancer von Muijlwijk, Tara, Nijenhuis, Dennis N L M, Ganzevles, Sonja H, Ekhlas, Fatima, Ballesteros-Merino, Carmen, Peferoen, Laura A N, Bloemena, Elisabeth, Fox, Bernard A, Poell, Jos B, Leemans, C René, Brakenhoff, Ruud H, van de Ven, Rieneke

    ISSN: 2051-1426, 2051-1426
    Veröffentlicht: England BMJ Publishing Group Ltd 24.07.2024
    Veröffentlicht in Journal for immunotherapy of cancer (24.07.2024)
    “… BackgroundApproximately 50% of head and neck squamous cell carcinomas (HNSCC) recur after treatment with curative intent. Immune checkpoint inhibitors are …”
    Volltext
    Journal Article